Scientists probe brain chemistry behind magic mushroom experiences
NCT ID NCT07565493
First seen May 07, 2026 · Last updated May 25, 2026 · Updated 5 times
Summary
This study looks at how blocking a certain serotonin receptor (5-HT1a) changes the effects of psilocybin, the active ingredient in magic mushrooms. Researchers will give 18 healthy adults psilocybin with or without a blocker drug and measure their experiences using surveys and brain wave tests. The goal is to understand the brain mechanisms behind psilocybin’s effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHEDELIC EFFECTS IN HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Psychedelics and Consciousness Research
Baltimore, Maryland, 21224-5010, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.